Practical Research that Identifies and Illuminates
ACPE UAN: 0233-0000-19-043-L04-P | Contact Hours: 1.25 | Activity Type: Knowledge-based
Karl J. Gregor, PharmD, MS
Vice President, Pharmacy Advisory Services
Optum
Fishers, Indiana
Drew Kirchner, FSA
Senior Actuarial Director
Cigna Healthcare
Denver, Colorado
Whitney S. Pratt, FSA, CERA, MAAA
Actuarial Manager
Optum
Englewood, Colorado
Stephen E. Wolff, PharmD, ASA, MAAA
Pharmacy Management Consultant
Milliman
Chicago, Illinois
Today, pharmacy costs are a higher percentage of the overall health care spend than in the past. The result is greater uncertainty in managing the financing of pharmacy benefits than ever before. To address this uncertainty, actuaries are now more active in designing pharmacy drug benefits, and are critical in projecting pharmacy costs, setting associated premiums, and influencing utilization management strategies. Actuaries also support various pharmacy stakeholders that must navigate complex operational, regulatory, and fiscal environments.
This session is designed to provide a fundamental understanding of actuarial roles, culture, language, methods and value drivers, and how they influence formulary decision-making and different lines of business.
At the completion of this activity, participants should be able to: